Cargando…
Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of unknown etiology with genetic predisposition. The advent of new biological agents, as well as the more traditional disease-modifying antirheumatic drugs, has resulted in highly efficient therapies for reducing the symptoms...
Autores principales: | Rego-Pérez, Ignacio, Fernández-Moreno, Mercedes, Blanco, Francisco J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691664/ https://www.ncbi.nlm.nih.gov/pubmed/19506728 http://dx.doi.org/10.2174/138920208785699553 |
Ejemplares similares
-
Role of TRAILR1 and TNFR1A polymorphisms in the susceptibility and pharmacogenetics of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
por: Morales-Lara, M J, et al.
Publicado: (2010) -
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
por: Ceballos, Francisco C., et al.
Publicado: (2023) -
Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies
por: O’Rielly, Darren D, et al.
Publicado: (2010) -
Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020) -
Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies
por: Standish, Kristopher A., et al.
Publicado: (2017)